Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma

被引：0
|
作者：
Ren, Jun
Amoozgar, Zohreh
Zhao, Yuhui
Lei, Pinji
Ho, William W.
Robergea, Sylvie
Huang, Peigen
Duda, Dan G.
Xu, Lei
Jain, Rakesh K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2343
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models
    Borodovsky, Alexandra
    Wang, Yanjun
    Ye, Minwei
    Shaw, Joseph C.
    Sachsenmeier, Kris
    Deng, Nanhua
    Goodwin, Kelly
    Clarke, James D.
    Goodwin, Richard
    Strittmatter, Nicole
    Hay, Carl
    Sah, Vasu
    Deborah, Lawson
    Reimer, Corinne
    Congreve, Miles
    Mason, Jonathan
    Marshall, Fiona
    Lyne, Paul
    Woessner, Richard
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation
    Xu, Xiaoyan
    Xie, Tingxue
    Zhou, Mengxin
    Sun, Yaqin
    Wang, Fengqi
    Tian, Yanan
    Chen, Ziyan
    Xie, Yanqi
    Wu, Ronghai
    Cen, Xufeng
    Zhou, Jichun
    Hou, Tingjun
    Zhang, Lei
    Huang, Chaoyang
    Zhao, Qingwei
    Wang, Dongrui
    Xia, Hongguang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [33] Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors
    Furlan, Scott N.
    Mandraju, Rajakumar
    Brewer, Travis
    Roybal, Kole
    Troutman, Ty Dale
    Hu, Wei
    Palm, Noah W.
    Unni, Arun
    Pasare, Chandrashekhar
    MABS, 2014, 6 (01) : 108 - 118
  • [34] Targeting the CXCR3 axis in HER2+breast cancer to enhance anti-tumor immunity
    Bhagat, Anchit
    Joseph, Jesuchristopher
    Ginzel, Joshua D.
    Rabiola, Christopher
    Hobeika, Amy C.
    Snyder, Joshua C.
    Lyerly, Herbert K.
    Crosby, Erika J.
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
    Jeanne, Albin
    Sarazin, Thomas
    Charle, Magalie
    Moali, Catherine
    Fichel, Caroline
    Boulagnon-Rombi, Camille
    Callewaert, Maite
    Andry, Marie-Christine
    Diesis, Eric
    Delolme, Frederic
    Rioult, Damien
    Dedieu, Stephane
    CANCERS, 2021, 13 (19)
  • [36] Assessment of CD4-mediated anti-tumor immunity in a BCR-ABL positive murine model of acute lymphoblastic leukemia
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 459 - 459
  • [37] Dato-DXd mediates anti-tumor activity in preclinical TROP2-expressing intracranial tumor model
    Jones, Kristen Jones
    Suksomboon, Montira
    Rosenthal, SaraAnn
    Gordon, Jacob
    Reimer, Corinne
    Sung, Matthew
    Rane, Chetan
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Blocking histamine receptor H1 on macrophages with anti-allergy drugs restores T-cell anti-tumor immunity.
    Li, Hongzhong
    Xiao, Yi
    Yao, Jun
    Yuan, Xiangliang
    Yin, Xuedong
    Zhang, Yuan
    Saito, Yohei
    Yagita, Hideo
    Gibbons, Don
    Yu, Dihua
    CANCER RESEARCH, 2021, 81 (13)
  • [39] Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma
    Eftimie, Raluca
    Bramson, Jonathan L.
    Earn, David J. D.
    JOURNAL OF THEORETICAL BIOLOGY, 2010, 265 (03) : 467 - 480
  • [40] Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model
    Lim, Soyeon
    Park, Jun-Hee
    Chang, Hyun
    INVESTIGATIVE AND CLINICAL UROLOGY, 2023, 64 (01) : 74 - 81
12345